Bulagsac, Dulcesima B.
HRN: 05-10-59 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2025
CEFTAZIDIME 1GM (VIAL)
01/16/2025
01/23/2025
IV
1gm
Q8h
CAP MR
Waiting Final Action
01/16/2025
LEVOFLOXACIN 500MG (TAB)
01/16/2025
01/23/2025
PO
750
OD
CAP MR
Waiting Final Action